Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bain

Showing results (81-90 of 494) with videos related to

Pageof 50
Sort By:
Mucosal Immunology|January 26, 2021
Guardians of the epithelium: macrophages protect against toxic fungal derivativesAllan M Mowat, Calum C Bain
Expert Review of Clinical Pharmacology|June 2, 2020
Semaglutide injection for the treatment of adults with type 2 diabetesRichard A Chudleigh, Stephen C Bain
The Medical Journal of Australia|May 19, 1979
Prescription drug advertising: medical journal practices under different types of controlJ M Najman, V Siskind, C Bain
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 19, 2024
The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic IsletsJoshua Reed, Stephen C Bain, Venkateswarlu Kanamarlapudi
Expert Review of Endocrinology & Metabolism|July 31, 2018
A systematic review of the safety of incretin-based therapies in type 2 diabetesMarc Evans, Stephen C Bain, Jiten Vora
The New England Journal of Medicine|November 21, 2019
Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. ReplyMansoor Husain, Morten Donsmark, Stephen C Bain
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitusJason Seewoodhary, Leanne Griffin, Stephen C Bain
Experimental Hematology|September 1, 1992
Protection of cells capable of reconstituting long-term bone marrow stromal cultures from 4-hydroperoxycyclophosphamide by interleukin 1 and tumor necrosis factorJ R Zucali, J Moreb, C Bain
Expert Opinion on Pharmacotherapy|July 29, 2016
Omarigliptin for the treatment of type 2 diabetes mellitusPhilip M S Evans, Stephen C Bain
Diabetic Medicine : a Journal of the British Diabetic Association|November 4, 2015
Role of incretin-based therapies and sodium-glucose co-transporter-2 inhibitors as adjuncts to insulin therapy in Type 2 diabetes, with special reference to IDegLiraJ P H Wilding, S C Bain
Pageof 50

Showing results (81-90 of 494) with videos related to

Sort By:
Pageof 50
Mucosal Immunology|January 26, 2021
Guardians of the epithelium: macrophages protect against toxic fungal derivativesAllan M Mowat, Calum C Bain
Expert Review of Clinical Pharmacology|June 2, 2020
Semaglutide injection for the treatment of adults with type 2 diabetesRichard A Chudleigh, Stephen C Bain
The Medical Journal of Australia|May 19, 1979
Prescription drug advertising: medical journal practices under different types of controlJ M Najman, V Siskind, C Bain
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 19, 2024
The Regulation of Metabolic Homeostasis by Incretins and the Metabolic Hormones Produced by Pancreatic IsletsJoshua Reed, Stephen C Bain, Venkateswarlu Kanamarlapudi
Expert Review of Endocrinology & Metabolism|July 31, 2018
A systematic review of the safety of incretin-based therapies in type 2 diabetesMarc Evans, Stephen C Bain, Jiten Vora
The New England Journal of Medicine|November 21, 2019
Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. ReplyMansoor Husain, Morten Donsmark, Stephen C Bain
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitusJason Seewoodhary, Leanne Griffin, Stephen C Bain
Experimental Hematology|September 1, 1992
Protection of cells capable of reconstituting long-term bone marrow stromal cultures from 4-hydroperoxycyclophosphamide by interleukin 1 and tumor necrosis factorJ R Zucali, J Moreb, C Bain
Expert Opinion on Pharmacotherapy|July 29, 2016
Omarigliptin for the treatment of type 2 diabetes mellitusPhilip M S Evans, Stephen C Bain
Diabetic Medicine : a Journal of the British Diabetic Association|November 4, 2015
Role of incretin-based therapies and sodium-glucose co-transporter-2 inhibitors as adjuncts to insulin therapy in Type 2 diabetes, with special reference to IDegLiraJ P H Wilding, S C Bain
Pageof 50